1

Teleflex

Teleflex
Leadership team

Mr. Liam J. Kelly (Chairman, Pres & CEO)

Mr. Thomas E. Powell (Exec. VP & CFO)

Mr. Cameron P. Hicks (Corp. VP & Chief HR Officer)

Products/ Services
Commercial, Health Care, Medical, Medical Device
Number of Employees
1,000 - 20,000
Headquarters
Royersford, Pennsylvania, United States
Established
1943
Company Registration
SEC CIK number: 0000096943
Net Income
500M - 1B
Revenue
Above - 1B
Social Media
Overview
Location
Summary
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
History

Teleflex was founded in 1943. Over time the business expanded into a conglomerate operating in multiple markets, often through acquisitions, such as:

Franklin Medical Ltd

Warne Surgical Products Ltd

Willy Rüsch AG

Pilling

Access Surgical

Nextex

Unimed

General Medical OEM Division

Europe Medical

Fehling

Simal

Endoscopy Specialists, Inc.

Asid Bonz

Comcorp Technologies, Inc. In general these acquisitions moved the business further into the design, build and supply of medical devices, a move that had begun in 1981 with the construction of the Applied Polymer plant in New Hampshire. Several acquisitions were not in line with this strategy. Comcorp, for example, was a supplier of pedals and other components for passenger cars and light-duty trucks and Nextex a fiber-optic communications business.

Refocus on the medical device sector began in March 2009 when Teleflex sold its marine and industrial instrumentation business to Veethree, and planned to exit its Lakewood Ranch, Florida facility. Veethree subsequently continued production of former Teleflex products at its Manatee County, Florida facility and hired approximately 50 workers from Teleflex.In March 2011, Teleflex sold its marine division, Teleflex Marine, to H.I.G. Capital.In August 2012, Teleflex substantively finalized an agreement to acquire all assets of the medical device maker LMA International, thereby expanding the company's anesthesia device franchise.In December 2013, Teleflex completed the acquisition of Vidacare Corporation, integrating Vidacare's intraosseous EZ-IO and OnControl medical devices into Teleflex's Arrow product line.On September 5, 2017, Teleflex announced that it had entered into a definitive agreement to acquire NeoTract in a transaction valued at up to $1.1B USD. Under the terms of the agreement, Teleflex will acquire NeoTract for an up-front cash payment of $725M USD and up to an additional $375M USD contingent on the achievement of certain sales-related commercial milestones through December 31, 2020. The transaction was unanimously approved by the Boards of Directors for both Teleflex and NeoTract.On January 18, 2019, S&P Dow Jones Indices added Teleflex to its S&P 500 stock market index. The company replaced PG&E in the index, a gas and power company, after the utility company announced it would declare bankruptcy on January 14, 2019.

Mission
Improve the health and quality of peoples' lives.
Vision
Become an innovative, highly trusted global provider of clinically relevant medical devices
Key Team

Mr. Jay White (Corp. VP & Pres of Global Commercial)

Mr. James P. Winters (Corp. VP, Manufacturing and Supply Chain)

Mr. John Hsu C.F.A. (VP of Investor Relations)

Mr. John R. Deren (Corp. VP & Chief Accounting Officer)

Mr. Daniel V. Logue (Corp. VP, Gen. Counsel & Sec.)

Mr. Matt Tomkin (VP of Corp. Devel.)

Mr. Howard Cyr (Corp. VP & Chief Compliance Officer)

Recognition and Awards
year-2020,awards-Medical Device & Diagnostic Industry’s Best Places to Work
References
Teleflex
Leadership team

Mr. Liam J. Kelly (Chairman, Pres & CEO)

Mr. Thomas E. Powell (Exec. VP & CFO)

Mr. Cameron P. Hicks (Corp. VP & Chief HR Officer)

Products/ Services
Commercial, Health Care, Medical, Medical Device
Number of Employees
1,000 - 20,000
Headquarters
Royersford, Pennsylvania, United States
Established
1943
Company Registration
SEC CIK number: 0000096943
Net Income
500M - 1B
Revenue
Above - 1B
Social Media